Evidence map›Paper›PMID 40993348›Full record

ArticleJournal of ophthalmic inflammation and infection2025

Common data elements for observational studies in ocular toxoplasmosis: a Delphi consensus.

William Rojas-Carabali, Carlos Cifuentes-González, Kerry Goetz, Maria Vittoria Cicinelli, Zheng Xian Thng, Sally L Baxter, Edmund Tsui, Padmamalini Mahendradas, Jyotirmay Biswas, Sofia Androudi and 26 more

Abstract read
In one paragraph

Article in Journal of ophthalmic inflammation and infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

William Rojas-CarabaliProgramme for Ocular Inflammation & Infection Translational Research, Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.
Carlos Cifuentes-GonzálezProgramme for Ocular Inflammation & Infection Translational Research, Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.
Kerry GoetzOffice of Data Science and Health Informatics, National Eye Institute, National Institutes of Health, Bethesda, MD, USA.
Maria Vittoria CicinelliSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Zheng Xian ThngDepartment of Ophthalmology, Tan Tock Seng Hospital, National Healthcare Group Eye Institute, Singapore, Singapore.
Sally L BaxterDivision of Ophthalmology Informatics and Data Science, Department of Ophthalmology and Shiley Eye Institute, Viterbi Family, University of California, La Jolla, San Diego, CA, USA.
Edmund TsuiUCLA Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Padmamalini MahendradasDepartment of Uveitis and Ocular Immunology, Narayana Nethralaya, Bengaluru, India.
Jyotirmay BiswasDirector of Uveitis & Ocular Pathology Department, Sankara Nethralaya, Chennai, India.
Sofia AndroudiDepartment of Ophthalmology, University of Thessaly, Volos, Greece.
Andre Luiz Land CuriInfectious Ophthalmology Laboratory, Evandro Chagas National Institute of Infectious Diseases-FIOCRUZ, Rio de Janeiro, Brazil.
Su Ling HoDepartment of Ophthalmology, Tan Tock Seng Hospital, National Healthcare Group Eye Institute, Singapore, Singapore.
Alfredo AdánHospital Clinic of Barcelona, Barcelona, Spain.
Rina La Distia NoraDepartment of Ophthalmology, Faculty of Medicine, University of Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Claudio SilveiraClínica Silveira, Erechim, Rio Grande do Sul, Brazil.
Heloisa NascimentoFederal University of São Paulo, São Paulo, Brazil.
João M FurtadoDivision of Ophthalmology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
Cristina MuccioliFederal University of São Paulo, São Paulo, Brazil.
Germán Mejía-SalgadoNeuroscience (NEUROS) Research Group, Neurovitae Center for Neuroscience, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.
Cristhian A UrzuaLaboratory of Ocular and Systemic Autoimmune Diseases, Faculty of Medicine, University of Chile, Santiago, Chile.
Justus G GarwegSwiss Eye Institute, Bern, Rotkreuz, Switzerland.
Ariel SchlaenHospital de Clínicas "José de San Martín", University of Buenos Aires/Hospital Universitario Austral, Buenos Aires, Argentina.
Xin WeiDepartment of Ophthalmology, Tan Tock Seng Hospital, National Healthcare Group Eye Institute, Singapore, Singapore.
Sivaraman BalamuruganDepartment of Uveitis and Ocular Inflammation, Aravind Eye Hospital, Thavalakuppam, Pondicherry, India.
Ranju Kharel SitaulaDepartment of Ophthalmology, B. P. Koirala Lions Centre for Ophthalmic Studies, Institute of Medicine, Tribhuvan University, Kathmandu, Nepal.
Ikhwanuliman PuteraDepartment of Ophthalmology, Faculty of Medicine, University of Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Marcelo RudzinskiUniversidad Católica de las Misiones, Posadas, Argentina.
Kalpana BabuPrabha Eye Clinic & Research Centre, Vittala International Institute of Ophthalmology, Bengaluru, India.
Mark WestcottBarts Health NHS Foundation Trust, London, UK.
Rubens BelfortFederal University of São Paulo, São Paulo, Brazil.
Justine R SmithCollege of Medicine & Public Health, Flinders Health & Medical Research Institute, Flinders University, Adelaide, Australia.
Jorge Gomez-MarinGrupo GEPAMOL, Facultad de Ciencias de la Salud, Universidad del Quindío, Armenia, Colombia.
Quan Dong NguyenByers Eye Institute, Stanford University, Palo Alto, CA, USA.
Vishali GuptaPost Graduate Institute of Medical Education and Research (PGIMER), Advance Eye Centre, Chandigarh, India.
Rupesh AgrawalProgramme for Ocular Inflammation & Infection Translational Research, Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore. rupeshttsh@gmail.com.
Alejandra de-la-TorreNeuroscience (NEUROS) Research Group, Neurovitae Center for Neuroscience, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia. alejadelatorre@yahoo.com.

Funding

San Diego Biomedical Informatics Education & Research (SABER)T15LM011271 · NLM · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SHAMIM NEMATI · 2012 to 2026
$9.7M
NLM NIH HHS T15 LM011271
6 · The paper itself

Abstract

purposeOcular toxoplasmosis (OT) is the most common cause of posterior uveitis globally, with a significant risk of visual impairment. However, the lack of standardized data collection hinders meaningful comparisons across studies. This study aimed to develop a consensus-based set of Common Data Elements (CDEs) for observational studies in OT using a Delphi approach.

designA set of CDEs was developed through a combination of a comprehensive literature review, a hybrid workshop, and a Delphi consensus process. This effort was led by an international panel of experts in OT to define a standardized CDE set for research and clinical purposes.

methodsA multidisciplinary steering committee identified an initial list of candidate CDEs through a targeted literature review. A panel of 30 international experts participated in a structured, one-round Delphi process to evaluate and refine these CDEs. Consensus was determined based on predefined thresholds for inclusion, exclusion, and modification.

resultsA total of 139 CDEs were categorized across nine domains: Demographic and Background Information, Medical and Ocular History, Clinical Presentation, Clinical Findings, Lesion Characteristics, Diagnostics, Imaging Findings, Treatment and Interventions, and Outcomes. All 139 CDEs met the inclusion criteria, with 79.8% rated as "very important". The consensus underscores the importance of a comprehensive, standardized dataset for OT research.

conclusionsThis study establishes the first expert-derived standardized dataset requested for reporting OT outcomes, providing a framework to standardize data collection for future observational studies. Adopting these CDEs will enhance data comparability, improve meta-analyses, and strengthen the evidence base for clinical decision-making in OT. Future work will focus on real-world validation and refinement of this dataset.

Indexed as

Clinical researchCommon data elementsDelphi consensusOcular toxoplasmosisStandardizationUveitis

Identifiers

PMID40993348
PMCPMC12460859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.